SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain 6.2% Stake in AnaptysBio Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a continued 6.2% beneficial ownership stake in AnaptysBio Inc. as of March 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 1,905,153.72 shares of AnaptysBio Inc. common stock.
- This ownership represents 6.2% of the total outstanding common stock of AnaptysBio Inc.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of AnaptysBio Inc.
- FMR LLC holds sole voting power over 1,904,656.00 shares.
- Both FMR LLC and Abigail P. Johnson hold sole dispositive power over 1,905,153.72 shares.
- The filing is an Amendment No. 1 to a previously filed Schedule 13G.
Sentiment
Score: 6
Explanation: The document is a routine beneficial ownership filing, which is inherently neutral. However, the continued significant stake (6.2%) held by a major institutional investor like FMR LLC and its principal, Abigail P. Johnson, can be interpreted as a mild positive signal of confidence in AnaptysBio Inc.
Positives
- A major institutional investor, FMR LLC, and its principal, Abigail P. Johnson, maintain a significant 6.2% beneficial ownership stake in AnaptysBio Inc., indicating continued investment interest and confidence.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of beneficial ownership by a large institutional asset manager, FMR LLC, and its principal, Abigail P. Johnson, in a publicly traded company, AnaptysBio Inc. Such filings are common for investors holding more than 5% of a company's shares and reflect ongoing portfolio management rather than specific industry trends for AnaptysBio itself.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, which can influence investor confidence and market perception.
Next Steps
- FMR LLC and Abigail P. Johnson will file further amendments to Schedule 13G if their beneficial ownership percentage changes by more than 1%.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC. |
| 01/10/2023 | Date of Schedule 13G filing by FMR LLC (accession number: -23-000003) referenced for Power of Attorney. |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 01/31/2023 | Date of Schedule 13G filing by FMR LLC (accession number: -23-000038) referenced for Power of Attorney. |
| 03/31/2025 | Date of event which requires the filing of this statement. |
| 05/09/2025 | Date of signing and filing of this Schedule 13G Amendment No. 1. |
Keywords
AnaptysBio Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.